Yale researchers have identified a drug target that may alleviate joint degeneration associated with osteoarthritis, a debilitating condition that afflicts as many as 30 million people in the United States alone, which they report in the journal Nature.
You may also be interested in:
Babies who are breastfed, or partially breastfed, for more than six months are less likely to be given sugar-sweetened drinks and sweet or salty snacks [...]
Increased numbers of preterm births, higher incidence of respiratory disease and death, and more children in hospitals are some of the stark health outcomes the [...]
After a one-year interdisciplinary therapy program that included clinical, nutritional, psychological and exercise counseling, a group of 22 obese adolescents not only lost weight but [...]